These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16990331)

  • 1. Acute renal failure from contrast medium: ... and remember simple and cheap measures.
    Patel A
    BMJ; 2006 Sep; 333(7569):653-4. PubMed ID: 16990331
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute renal failure induced by contrast medium: steps towards prevention.
    Mathew R; Haque K; Woothipoom W
    BMJ; 2006 Sep; 333(7567):539-40. PubMed ID: 16960210
    [No Abstract]   [Full Text] [Related]  

  • 3. Additional data supporting the use of statins to prevent contrast induced nephropathy.
    Pappy R; Abu-Fadel MS
    Int J Cardiol; 2011 Oct; 152(2):265-6. PubMed ID: 21872353
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: risk factors for contrast-related acute kidney injury according to risk, injury, failure, loss, and end-stage criteria in patients with coronary interventions.
    Mahdavi-Mazdeh M
    Iran J Kidney Dis; 2010 Jul; 4(3):269-70. PubMed ID: 20622321
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal replacement therapy for prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials.
    Song K; Jiang S; Shi Y; Shen H; Shi X; Jing D
    Am J Nephrol; 2010; 32(5):497-504. PubMed ID: 20975263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute renal failure caused by contrast - as is always the most important prevention].
    Bryniarski L
    Kardiol Pol; 2010 Sep; 68(9):1021-2. PubMed ID: 20859893
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk Factors for contrast-related acute kidney injury according to risk, injury, failure, loss, and end-stage criteria in patients with coronary interventions.
    Pakfetrat M; Nikoo MH; Malekmakan L; Tabande M; Roozbeh J; Reisjalali G; Zare N; Khajedehi P
    Iran J Kidney Dis; 2010 Apr; 4(2):116-22. PubMed ID: 20404421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
    ACT Investigators
    Circulation; 2011 Sep; 124(11):1250-9. PubMed ID: 21859972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renalguard system: a dedicated device to prevent contrast-induced acute kidney injury.
    Briguori C
    Int J Cardiol; 2013 Sep; 168(2):643-4. PubMed ID: 22236513
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
    Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
    Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of contrast-medium-induced acute renal failure].
    Hou F
    Zhonghua Nei Ke Za Zhi; 2001 Nov; 40(11):723-4. PubMed ID: 11930673
    [No Abstract]   [Full Text] [Related]  

  • 12. Iodinated contrast media and the role of renal replacement therapy.
    Weisbord SD; Palevsky PM
    Adv Chronic Kidney Dis; 2011 May; 18(3):199-206. PubMed ID: 21531326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iopamidol is a safe choice in the practice of diagnostic imaging].
    Filatov DN; Cherkavskaia OV; Korobkova IZ
    Vestn Rentgenol Radiol; 2011; (3):69-72. PubMed ID: 22288139
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal protection: preconditioning for the prevention of contrast-induced nephropathy.
    Ozsvath KJ; Darling RC
    Semin Vasc Surg; 2013 Dec; 26(4):144-9. PubMed ID: 25220319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxicity of contrast media and protective effects of acetylcysteine.
    Briguori C; Quintavalle C; De Micco F; Condorelli G
    Arch Toxicol; 2011 Mar; 85(3):165-73. PubMed ID: 21140133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A drug to prevent renal failure?
    Kellum JA
    Lancet; 2003 Aug; 362(9384):589-90. PubMed ID: 12944054
    [No Abstract]   [Full Text] [Related]  

  • 17. Forced diuresis with the RenalGuard system: impact on contrast induced acute kidney injury.
    Solomon R
    J Cardiol; 2014 Jan; 63(1):9-13. PubMed ID: 24239195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of contrast-related renal failure.
    Bettmann MA
    AJR Am J Roentgenol; 1991 Jul; 157(1):66-8. PubMed ID: 2048541
    [No Abstract]   [Full Text] [Related]  

  • 19. Does hydration prevent contrast material renal injury?
    Talner LB
    AJR Am J Roentgenol; 1981 May; 136(5):1021-2. PubMed ID: 6784504
    [No Abstract]   [Full Text] [Related]  

  • 20. Is it possible to prevent acute kidney injury in patients who underwent contrast medium?
    Fidanci MK; Kurkluoglu M; Guler A; Yesil FG; Balta S; Arslan Z
    Angiology; 2014 Mar; 65(3):224. PubMed ID: 23599506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.